BioXcel Therapeutics Ownership | Who Owns BioXcel Therapeutics?
BioXcel Therapeutics Ownership Summary
BioXcel Therapeutics is owned by 7.82% institutional investors, 3.78% insiders, and 88.40% retail investors. Oaktree capital management lp is the largest institutional shareholder, holding 3.08% of BTAI shares. BSO Bio Santé C is the top mutual fund, with 2.26% of its assets in BioXcel Therapeutics shares.
BTAI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioXcel Therapeutics | 7.82% | 3.78% | 88.40% |
| Sector | Healthcare Stocks | 486.50% | 11.08% | -397.59% |
| Industry | Biotech Stocks | 304.14% | 11.08% | -215.23% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Oaktree capital management lp | 241.19K | 3.08% | $436.55K |
| Blackrock | 440.69K | 1.43% | $564.08K |
| Murchinson | 80.62K | 1.03% | $145.92K |
| Charles schwab investment management | 203.62K | 0.66% | $260.63K |
| Oaktree fund advisors | 42.91K | 0.55% | $77.67K |
| Morgan stanley | 116.56K | 0.38% | $149.20K |
| Jones financial companies lllp | 26.00K | 0.33% | $46.02K |
| Goldman sachs group | 98.97K | 0.32% | $126.68K |
| Xtx topco | 23.42K | 0.30% | $42.40K |
| Beacon pointe advisors | 18.84K | 0.24% | $34.11K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Oaktree fund advisors | 42.91K | 0.13% | $77.67K |
| Murchinson | 80.62K | 0.05% | $145.92K |
| Oaktree capital management lp | 241.19K | 0.01% | $436.55K |
| Diversify wealth management | 15.00K | 0.01% | $102.00K |
| Xtx topco | 23.42K | 0.00% | $42.40K |
| Beacon pointe advisors | 18.84K | 0.00% | $34.11K |
| Allsquare wealth management | 175.00 | 0.00% | $317.00 |
| Thrivent financial for lutherans | 40.00K | 0.00% | $51.00K |
| Renaissance | 77.90K | - | $29.13K |
| Toth financial advisory | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Oaktree capital management lp | 241.19K | 0.01% | 241.19K |
| Goldman sachs group | 98.97K | - | 76.20K |
| Oaktree fund advisors | 42.91K | 0.13% | 42.91K |
| Bank of america corp /de/ | 73.43K | - | 26.06K |
| Jones financial companies lllp | 26.00K | - | 26.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | - | - | -4.32M |
| Fmr | - | - | -2.21M |
| Ubs group | - | - | -1.28M |
| Vanguard group | - | - | -1.19M |
| Blackrock | 440.69K | - | -887.38K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Oaktree capital management lp | 241.19K | 0.01% | 241.19K | $436.55K |
| Oaktree fund advisors | 42.91K | 0.13% | 42.91K | $77.67K |
| Jones financial companies lllp | 26.00K | - | 26.00K | $46.02K |
| Xtx topco | 23.42K | 0.00% | 23.42K | $42.40K |
| Diversify wealth management | 15.00K | 0.01% | 15.00K | $102.00K |
Sold Out
| Holder | Change |
|---|---|
| Citigroup | -3.00 |
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Farther finance advisors | -5.00 |
| Us bancorp \de\ | -33.00 |
| Point72 (difc) | -35.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 32 | 3.23% | 613,025 | 61.47% | 7 | 797.16% | 14 | 100.00% | 7 | -70.83% |
| Mar 31, 2025 | 1 | -97.92% | 661 | -99.99% | - | 0.85% | 1 | -94.74% | - | -100.00% |
| Dec 31, 2024 | 13 | -74.00% | 537,273 | -82.68% | 1 | 2.37% | 4 | -63.64% | 6 | -77.78% |
| Sep 30, 2024 | 50 | -33.33% | 3,102,869 | -68.25% | 7 | 0.73% | 12 | -72.73% | 27 | 50.00% |
| Jun 30, 2024 | 75 | -2.60% | 9,773,375 | 5.76% | 31 | 3.15% | 44 | 51.72% | 18 | -28.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BSO Bio Santé C | 70.00K | 2.26% | - |
| Vanguard Total Stock Mkt Idx Inv | 55.39K | 1.73% | - |
| Fidelity Growth Compy Commingled Pl O | 469.48K | 1.15% | -425.27K |
| Vanguard US Total Market Shares ETF | 886.24K | 1.01% | -1.00 |
| Fidelity Growth Company Fund | 353.64K | 0.87% | -248.67K |
| Vanguard Institutional Extnd Mkt Idx Tr | 43.45K | 0.66% | 25.12K |
| Fidelity Growth Company K6 | 163.94K | 0.40% | -132.22K |
| Fidelity Extended Market Index | 14.23K | 0.23% | - |
| Fidelity Series Growth Company | 88.26K | 0.22% | -63.60K |
| NT R2000 Growth Index Fund - NL | 57.60K | 0.14% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 16, 2024 | O'Neill Vincent | See Remarks | Sell | $58.13 |
| Dec 16, 2024 | Mehta Vimal | CEO and President | Sell | $773.36 |
| Dec 16, 2024 | Mehta Vimal | CEO and President | Sell | $357.91 |
| Dec 16, 2024 | Steinhart Richard I | Chief Financial Officer | Sell | $73.80 |
| Dec 16, 2024 | Steinhart Richard I | Chief Financial Officer | Sell | $133.18 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 12 |
| 2024 Q3 | - | 7 |
BTAI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools